AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2009
Mar 25, 2009
30786_dirs_2009-03-25_409fc8c2-1ffb-409f-b805-692d1410010d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2009-03-24
Reporting Person: GOETZ JOHN (Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-03-24 | Bio-Rad A Common Stock | M | 5680 | $11.94 | Acquired | 27046.4255 | Direct |
| 2009-03-24 | Bio-Rad A Common Stock | M | 658 | $10.75 | Acquired | 27704.4255 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-03-24 | Incentive Stock Option (right to buy) | $11.94 | M | 5680 | Disposed | 2010-02-02 | Bio-Rad A Common Stock (5680) | Direct |
| 2009-03-24 | Non-Qualified Stock Option (right to buy) | $10.75 | M | 658 | Disposed | 2010-09-19 | Bio-Rad A Common Stock (658) | Direct |
Footnotes
F1: Includes 30.4081, 38.6849 and 34.2471 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 6/30/08, 9/30/08 and 12/31/08, respectively.
F2: The stock option vested over four years at 25% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13